| Literature DB >> 30027800 |
Nini Wang1,2, Tingting Zhu1, Yuhong Tao1.
Abstract
OBJECTIVE: This study aimed to analyze the clinicopathological features of pediatric renal biopsies from plateau regions of China.Entities:
Keywords: Renal biopsy; glomerulonephritis; hematuria; nephrotic syndrome; pathology; plateau
Mesh:
Year: 2018 PMID: 30027800 PMCID: PMC6259398 DOI: 10.1177/0300060518786908
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Main pathological diagnoses of renal biopsy samples from children according to sex in the plateau and non-plateau groups.
Plateau group (n = 169) | Non-plateau group (n = 575) | |||
|---|---|---|---|---|
| Pathological diagnosis | Boys | Girls | Boys | Girls |
| Primary glomerular disease | 43 (46.24) | 34 (44.74) | 236 (66.11) | 121 (55.50) |
| Secondary glomerular disease | 49 (52.69) | 41 (53.95) | 114 (31.93) | 93 (42.66) |
| Hereditary glomerular disease | 0 | 1 (1.32) | 5 (1.40) | 2 (0.92) |
| Renal tubulointerstitial disease | 1 (1.08) | 0 | 2 (0.56) | 2 (0.92) |
| Total | 93 | 76 | 357 | 218 |
Values are the number of cases (%).
Main pathological diagnoses of renal biopsy samples from children of different ages in the plateau and non-plateau groups.
Plateau group (n = 169) | Non-plateau group (n = 575) | ||||||
|---|---|---|---|---|---|---|---|
| Pathological diagnosis | Age <5 years | Age 6–14 years | Age 15–18 years | Age <5 years | Age 6–14 years | Age 15–18 years | |
| Primary glomerular disease | 15 (68.18) | 60 (41.67) | 2 (66.67) | 60 (76.92) | 279 (59.49) | 18 (64.29) | |
| Secondary glomerular disease | 6 (27.27) | 83 (57.64) | 1 (33.33) | 14 (17.95) | 183 (39.02) | 10 (35.71) | |
| Hereditary glomerular disease | 0 | 1 (0.69) | 0 | 2 (2.56) | 5 (1.07) | 0 | |
| Renal tubulointerstitial disease | 1 (4.55) | 0 | 0 | 2 (2.56) | 2 (0.43) | 0 | |
| Total | 22 | 144 | 3 | 78 | 469 | 28 | |
Values are the number of cases (%).
Clinicopathological features of primary glomerular disease in the plateau and non-plateau groups.
| Pathological diagnosis | NS | Hematuria pending diagnosis | AGN | RPGN | CGN | Proteinuria | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Plateau | Non-plateau | Plateau | Non-plateau | Plateau | Non-plateau | Plateau | Non-plateau | Plateau | Non-plateau | Plateau | Non-plateau | Plateau | Non-plateau | |
| MGA | 17 (32.69) | 92 (44.23) | 6 (28.57) | 55 (44) | 0 | 3 (25.00) | 0 | 0 | 0 | 0 | 0 | 2 (100) | 23 (29.87) | 152 (42.58) |
| IgAN | 19 (36.54) | 45 (21.63) | 13 (61.9) | 53 (42.4) | 0 | 1(8.33) | 0 | 1 (100) | 0 | 0 | 0 | 0 | 32 (41.56) | 100 (28.01) |
| MsPGN | 2 (3.85) | 18 (8.65) | 1 (4.76) | 13 (10.40) | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3 (3.90) | 32 (8.96) |
| MPGN | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 (100) | 0 | 0 | 0 | 1 (1.30) | 0 | |
| MN | 4 (7.69) | 9 (4.33) | 0 | 1 (0.80) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 (5.19) | 10 (2.80) |
| EnPGN | 2 (3.85) | 9 (4.33) | 1 (4.76) | 0 | 2 (100) | 7 (58.33) | 0 | 0 | 0 | 0 | 0 | 0 | 5 (6.49) | 16 (4.48) |
| CreGN | 3 (5.77) | 1 (0.48) | 0 | 0 | 0 | 0 | 1 (100) | 0 | 0 | 0 | 0 | 0 | 4 (5.19) | 1 (0.28) |
| FSGS | 4 (7.69) | 30 (14.42) | 0 | 3 (2.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 (5.19) | 33 (9.24) |
| SGN | 1 (1.92) | 4 (1.92) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 (100) | 0 | 0 | 1 (1.30) | 13 (3.64) |
| Total | 52 | 208 | 21 | 125 | 2 | 12 | 1 | 1 | 1 | 9 | 0 | 2 | 77 | 357 |
Values are the number of cases (%). NS, nephrotic syndrome; AGN, acute glomerulonephritis; RPGN, rapid progressive glomerulonephritis; CGN, chronic glomerulonephritis; MGA, minor glomerular abnormalities; IgAN, IgA nephropathy; MsPGN, mesangial proliferative glomerulonephritis without IgA deposition; MPGN, membranoproliferative glomerulonephritis; MN, membranous nephropathy; EnPGN, endocapillary proliferative glomerulonephritis; CreGN, crescentic glomerulonephritis; FSGS, focal segmental glomerulosclerosis and sclerosing nephritis; SGN, sclerosing glomerulonephritis.
Main diagnoses of non-primary glomerulonephritis in the plateau and non-plateau groups.
| Diagnosis | Plateau group(n = 92) | Non-plateau group(n = 218) | Total(n = 310) |
|---|---|---|---|
| Secondary glomerular disease | 90 (100) | 207 (100) | 297 (100) |
| Henoch-Schönlein purpura nephritis | 71 (78.89) | 135 (65.22) | 206 (69.36) |
| Lupus nephritis | 6 (6.67) | 45 (21.74) | 51 (17.17) |
| HBV-associated glomerulonephritis | 11 (12.22) | 11 (5.31) | 22 (7.41) |
| ANCA-associated glomerulonephritis | 1 (1.11) | 4 (1.93) | 5 (1.68) |
| Hemolytic uremic syndrome | 0 (0) | 3 (1.45) | 3 (1.01) |
| Others | 1 (1.11) | 9 (4.35) | 10 (3.37) |
| Hereditary glomerular disease | 1 (100) | 7 (100) | 8 (100) |
| Hereditary nephritis | 1 (100) | 4 (57.14) | 5 (62.50) |
| Thin basement membrane nephropathy | 0 | 3 (42.86) | 3 (37.50) |
| Renal tubulointerstitial disease | 1 (100) | 4 (100) | 5 (100) |
Values are the number of cases (%). HBV, hepatitis B virus; ANCA, anti-neutrophil cytoplasmic antibody.